Vioxx users who claim the drug increased their risk of heart ailments may pursue their class action suit against Merck & Co. Inc. for funding of a medical monitoring program.

A New Jersey appeals court, while expressing no opinion on the viability of the product liability claims, ruled that the trial judge had dismissed them too hastily, simply because the plaintiffs had not demonstrated harm.